Seagen Inc.
Q1 2022 Earnings Call
Apr 28, 2022, 4:30 p.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Good day, and welcome to the Seagen first quarter 2022 financial results conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the conference over to Mr. Clay Siegall.
Please go ahead, sir.
Peggy Pinkston -- Senior Vice President of Investor Relations
Thank you, operator, and good afternoon, everyone. I'm pleased to welcome you to Seagen's first quarter 2022 financial results conference call. This afternoon, we issued a press release with our results, and that press release and supporting slides are available on our website in the Investors section, Events and Presentations page. Speakers on today's call will be Clay Siegall, president and chief executive officer; Todd Simpson, chief financial officer; Chip Romp, executive vice president, commercial U.S.; and Roger Dansey, chief medical officer.
Following our prepared remarks, we'll open the line for questions, and we aim to keep this call to one hour. [Operator instructions] Today's conference call will include forward-looking statements regarding future or anticipated events and results, including the company's 2022 financial outlook, anticipated product sales, revenues, costs and expenses, future developments related to legal matters, and potential clinical and regulatory milestones, including data readouts, regulatory submissions, and potential marketing and reimbursement approvals. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include the difficulty in forecasting sales, revenues, and expenses, impacts related to the COVID-19 pandemic, and the uncertainty associated with legal disputes and with the pharmaceutical development and regulatory approval process.
More information about the risks and uncertainties faced by Seagen is contained under the caption Risk Factors included in the company's annual report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission and the company's subsequent reports filed with the SEC. And now, I'll turn the call over to Clay.
Clay Siegall -- President and Chief Executive Officer
Thank you, Peg. Good afternoon, everyone, and welcome to our first quarter call. We are pleased to report total revenues of $426 million for the first quarter. This includes net product sales of $383 million, representing 27% growth over the first quarter of last year.